- Report
- January 2025
- 165 Pages
Global
From €2590EUR$2,850USD£2,200GBP
- Report
- March 2025
- 193 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 195 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- February 2025
- 135 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- April 2025
- 272 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- July 2024
- 185 Pages
Global
From €2272EUR$2,500USD£1,930GBP
- Report
- July 2024
- 185 Pages
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- October 2024
- 200 Pages
Global
From €4498EUR$4,949USD£3,820GBP
- Report
- October 2024
- 70 Pages
United States
From €863EUR$950USD£733GBP
- Report
- October 2024
- 70 Pages
Latin America
From €863EUR$950USD£733GBP
- Report
- January 2025
Global
From €4499EUR$4,950USD£3,821GBP
- Report
- May 2024
- 106 Pages
North America
From €3136EUR$3,450USD£2,663GBP
- Report
- March 2025
- 187 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 197 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 195 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 185 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- April 2025
- 82 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 72 Pages
Global
From €5317EUR$5,850USD£4,515GBP

The Cardiac Marker market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs and other treatments for cardiovascular diseases. Cardiac markers are substances that are released into the bloodstream when the heart is damaged or stressed. These markers can be used to diagnose and monitor the progression of cardiovascular diseases, such as heart attack, stroke, and congestive heart failure. The market is driven by the increasing prevalence of cardiovascular diseases, the growing demand for early diagnosis and treatment, and the development of new technologies.
The Cardiac Marker market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more